» Articles » PMID: 23907171

CAS9 Transcriptional Activators for Target Specificity Screening and Paired Nickases for Cooperative Genome Engineering

Overview
Journal Nat Biotechnol
Specialty Biotechnology
Date 2013 Aug 3
PMID 23907171
Citations 942
Authors
Affiliations
Soon will be listed here.
Abstract

Prokaryotic type II CRISPR-Cas systems can be adapted to enable targeted genome modifications across a range of eukaryotes. Here we engineer this system to enable RNA-guided genome regulation in human cells by tethering transcriptional activation domains either directly to a nuclease-null Cas9 protein or to an aptamer-modified single guide RNA (sgRNA). Using this functionality we developed a transcriptional activation-based assay to determine the landscape of off-target binding of sgRNA:Cas9 complexes and compared it with the off-target activity of transcription activator-like (TALs) effectors. Our results reveal that specificity profiles are sgRNA dependent, and that sgRNA:Cas9 complexes and 18-mer TAL effectors can potentially tolerate 1-3 and 1-2 target mismatches, respectively. By engineering a requirement for cooperativity through offset nicking for genome editing or through multiple synergistic sgRNAs for robust transcriptional activation, we suggest methods to mitigate off-target phenomena. Our results expand the versatility of the sgRNA:Cas9 tool and highlight the critical need to engineer improved specificity.

Citing Articles

Tuning the tropism and infectivity of SARS-CoV-2 virus-like particles for mRNA delivery.

Yang Q, Davidson B, Pajic P, Chen X, Gokcumen O, Gao M Nucleic Acids Res. 2025; 53(5).

PMID: 40037714 PMC: 11879429. DOI: 10.1093/nar/gkaf133.


Dynamic properties of transcriptional condensates modulate CRISPRa-mediated gene activation.

Fu Y, Yang X, Li S, Ma C, An Y, Cheng T Nat Commun. 2025; 16(1):1640.

PMID: 39952932 PMC: 11828908. DOI: 10.1038/s41467-025-56735-8.


Multi-locus CRISPRi targeting with a single truncated guide RNA.

Moore M, Wekhande S, Issner R, Collins A, Cruz A, Liu Y Nat Commun. 2025; 16(1):1357.

PMID: 39905017 PMC: 11794626. DOI: 10.1038/s41467-025-56144-x.


High-accuracy crRNA array assembly strategy for multiplex CRISPR.

Zhao X, Yang L, Li P, Cheng Z, Jia Y, Luo L Mol Ther Nucleic Acids. 2025; 36(1):102428.

PMID: 39897580 PMC: 11787013. DOI: 10.1016/j.omtn.2024.102428.


Recent progress in prompt molecular detection of liquid biopsy using Cas enzymes: innovative approaches for cancer diagnosis and analysis.

Yazdi Z, Roshannezhad S, Sharif S, Abbaszadegan M J Transl Med. 2024; 22(1):1173.

PMID: 39741289 PMC: 11686959. DOI: 10.1186/s12967-024-05908-y.


References
1.
Boch J, Scholze H, Schornack S, Landgraf A, Hahn S, Kay S . Breaking the code of DNA binding specificity of TAL-type III effectors. Science. 2009; 326(5959):1509-12. DOI: 10.1126/science.1178811. View

2.
Hwang W, Fu Y, Reyon D, Maeder M, Tsai S, Sander J . Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat Biotechnol. 2013; 31(3):227-9. PMC: 3686313. DOI: 10.1038/nbt.2501. View

3.
Maeder M, Linder S, Reyon D, Angstman J, Fu Y, Sander J . Robust, synergistic regulation of human gene expression using TALE activators. Nat Methods. 2013; 10(3):243-5. PMC: 3584229. DOI: 10.1038/nmeth.2366. View

4.
Gasiunas G, Barrangou R, Horvath P, Siksnys V . Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc Natl Acad Sci U S A. 2012; 109(39):E2579-86. PMC: 3465414. DOI: 10.1073/pnas.1208507109. View

5.
Perez-Pinera P, Ousterout D, Brunger J, Farin A, Glass K, Guilak F . Synergistic and tunable human gene activation by combinations of synthetic transcription factors. Nat Methods. 2013; 10(3):239-42. PMC: 3719416. DOI: 10.1038/nmeth.2361. View